Biotech RadarJobs updated

COMPANY

Bluejay Diagnostics

HQ: Acton, MA source · bluejaydx.com ↗ · New England

Keywords: diagnostics Severe Sepsis Septic Shock Sepsis Sepsis Septic Shock

Location: Acton, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

7Trials (company is sponsor)

Timeline

  1. Partnership Partnership / licensing announced Sep 8, 2026. Source: SEC filing. source ↗
  2. Trial start —: Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study source ↗
  3. Partnership Partnership / licensing announced Oct 9, 2025. Source: SEC filing. source ↗
  4. Trial start —: Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study source ↗
  5. Trial start —: Multicenter Symphony IL-6 Monitoring Sepsis ICU Study source ↗
  6. Trial start —: Symphony IL-6 Study in Patients at Risk of Severe Sepsis source ↗
  7. Trial start —: Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19 source ↗
  8. Trial start —: Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis source ↗
  9. Trial start —: Symphony IL-6 Reference Range Study source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Last 2 years.

Clinical trials (lead sponsor) 7

RecordTitlePhaseStatusStartPrimary completion
NCT06654895Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation StudyNot listedActive, not recruitingNov 12, 2024Dec 31, 2026 (estimated)
NCT07425587Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot StudyNot listedActive, not recruitingMay 4, 2026Dec 30, 2026 (estimated)
NCT06181604Multicenter Symphony IL-6 Monitoring Sepsis ICU StudyNot listedCompletedJan 12, 2024Jul 12, 2024 (actual)
NCT05665153Symphony IL-6 Study in Patients at Risk of Severe SepsisNot listedUnknown status (ClinicalTrials.gov)Nov 22, 2022Aug 21, 2024 (estimated)
NCT05060250Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19Not listedUnknown status (ClinicalTrials.gov)Aug 31, 2021Nov 30, 2024 (estimated)
NCT05048927Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe SepsisNot listedUnknown status (ClinicalTrials.gov)Aug 31, 2021Nov 30, 2024 (estimated)
NCT05048888Symphony IL-6 Reference Range StudyNot listedUnknown status (ClinicalTrials.gov)Aug 31, 2021Mar 30, 2024 (estimated)
Feedback